Atea Pharmaceuticals, Inc. (AVIR) Share-based Payment Arrangement, Expense USD 2019 - 2024

Historical data

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Atea Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2024.
Atea Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $12.6 M, a 0.41% increase year-over-year.
Atea Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $49.5 M, a 3.97% increase year-over-year.
Atea Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $49.4 M, a 5.8% increase from 2022.
Atea Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $46.7 M, a 17.9% increase from 2021.
Atea Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $39.6 M, a 431% increase from 2020.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2024	$49.5 M	$12.6 M	+$51 K	+0.41%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-14
Q4 2023	$49.4 M	$12.2 M	+$512 K	+4.4%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-28
Q3 2023	$48.9 M	$12.4 M	+$879 K	+7.64%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-08
Q2 2023	$48 M	$12.4 M	+$445 K	+3.74%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-08
Q1 2023	$47.6 M	$12.5 M	+$874 K	+7.5%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-14
Q4 2022	$46.7 M	$11.6 M	+$294 K	+2.59%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-28
Q3 2022	$46.4 M	$11.5 M	+$514 K	+4.68%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-08
Q2 2022	$45.9 M	$11.9 M	+$1.9 M	+19%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-08
Q1 2022	$44 M	$11.7 M	+$4.39 M	+60.3%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-08
Q4 2021	$39.6 M	$11.4 M	+$8.53 M	+302%	Oct 1, 2021	Dec 31, 2021	10-K	2023-02-28
Q3 2021	$31.1 M	$11 M	+$6.75 M	+159%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-07
Q2 2021	$24.3 M	$10 M	+$9.8 M	+4688%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-08
Q1 2021	$14.5 M	$7.27 M	+$7.08 M	+3748%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-10
Q4 2020	$7.46 M	$2.82 M			Oct 1, 2020	Dec 31, 2020	10-K	2023-02-28
Q3 2020		$4.24 M	+$4.08 M	+2599%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-12
Q2 2020		$209 K			Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-12
Q1 2020		$189 K			Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-13
Q3 2019		$157 K			Jul 1, 2019	Sep 30, 2019	10-Q	2020-12-10

* An asterisk sign (*) next to the value indicates that the value is likely invalid.